Browsing: drug

ByteDance closed a $290M funding round for Anew Labs, its newly spun-off AI drug discovery unit, at a $1.5B valuation, Reuters reports, citing two sources familiar with the matter. Moreover, the company that owns TikTok will retain 56% of the business after this round, according to the same sources. 

The poor reader of today’s news is bombarded by articles hyping AI or their doom and gloom opposite. This dichotomy exists even in biopharma. Grand proclamations of the technology’s ability to accelerate novel drugs to market or sift through the scientific literature to find undiscovered targets run alongside articles that rail about how artificial intelligence…

CHINA / SOCIETY China’s first AI-assisted innovative drug approved for marketing: media

Jim Cramer is flagging an Amgen drug that Wall Street has largely ignored, and he thinks the cardiovascular opportunity behind it could rival the most valuable pharmaceutical market ever created.

I knew I’d officially become a “longevity influencer” this month when a company called Generation Lab reached out to offer me the chance to write about—and even receive—their new rejuvenation treatment, an injectable combination of two existing drugs which they call 1 Generation.

ALTERITY THERAPEUTICS LIMITED (ATHE) filed an annual report describing its development-stage neurology business focused on ATH434 for multiple system atrophy (MSA) and other Parkinsonian disorders. ATH434 is the lead and highly concentrated asset; Alterity reported positive FDA feedback and End‑of‑Phase 2 alignment on key elements of a registrational Phase 3 program.

The deal is valued at over $1.5 billion and will grant Sentivera global rights to develop, manufacture, and commercialize a preclinical drug targeting type 2 inflammatory diseases, excluding Greater China.

Artificial intelligence (AI) in drug discovery has attracted increasing interest over the past decade. It is now time for a critical review of progress in the field: where did we advance — and where are we yet to see impact — when it comes to what matters in drug discovery, which is to deliver safer…